Replies to post #2895 on Radient Pharmaceuticals Corporation fka RXPC

[Future Doc]

With the current state of health-care, whatever that actually is, it seems we are headed toward a medically frugal environment. The cost of a test will most certainly come into play when considering diagnostic options. this will especially be important if the patients have to subsidize a portion of the bill. Dealing with insurance companies and being reimbursed for medical procedures, tests, supplies etc are the absolute most painful processes in the medical world: whether it be for small offices or large hospital systems. It is much easier to have a company reimburse you for a cheap test than an expensive one.